Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

In search for an innovative neural marker and intervention for socio-communicative difficulties in children with and without autism spectrum disorders

Trial Profile

In search for an innovative neural marker and intervention for socio-communicative difficulties in children with and without autism spectrum disorders

Recruiting
Phase of Trial: Phase III/IV

Latest Information Update: 11 Oct 2018

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Autistic disorder
  • Focus Therapeutic Use
  • Acronyms MOX
  • Most Recent Events

    • 06 Oct 2018 Status changed from not stated to recruiting.
    • 10 Jul 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top